Johan Lindberg
About me
Principal Researcher at the Department of Medical Epidemiology and Biostatistics (MEB), ̽»¨¾«Ñ¡, with a focus on biomarker discovery and cancer genomics assay development. Leading a multidisciplinary team comprising PhD students, postdocs, engineers, and bioinformaticians.
My team has established and is responsible for a sample- and analysis process at KI/SciLife to enable biomarker driven randomized clinical trials and prospective research projects. The process encompasses reception and storage of biomaterial, subsequent processing for Illumina sequencing and analysis using an in-house developed bioinformatics pipeline and curation software. The setup is made possible through collaboration with KI biobank and Clinical Genomics at SciLife lab. Since 2016 >5500 samples from >50 hospitals in 6 European countries has been analysed and reported. The main studies have been ALASCCA and . The first result from the ProBio trial was and the ALASCCA trial met its primary endpoint which was recently presented at .
The sample- and analysis process has been optimized, enabling a two-week turnover of results even to trial sites in other countries such as Belgium. Consequently, the weekly team activities have strong similarities to a routine diagnostic setting with tight timelines and uptime requirements. To give patients in clinical routine access to improved diagnostics and state-of-the art genomics the iPCM (implementation of Personalized Cancer Medicine) project was launched in late 2020 with the goal to implement the research infrastructure for genomic profiling in clinical routine at Clinical Pathology, Karolinska Hospital. Hitherto, genomic analysis of and has been implemented as routine diagnostic tests with many more yet to come.
Research
Cancer genomics, liquid biopsy, assay development, clinical trials.
Teaching
Teaching subject area: Genetics, Cancer Genomics, Biotechnology, Bioinformatics.
Responsible for the annual course . The course is aimed towards PhD students and postdocs performing research in the subject area.
Course evaluations are available from and .
Articles
- Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2025;43(4_SUPPL):lba125
- Article: CANCERS. 2024;16(22):3816
- Article: NATURE MEDICINE. 2024;30(11):3291-3302
- Journal article: ANNALS OF ONCOLOGY. 2024;35:s991-s992
- Journal article: ANNALS OF ONCOLOGY. 2024;35:s978
- Journal article: ANNALS OF ONCOLOGY. 2024;35:s987
- Journal article: ANNALS OF ONCOLOGY. 2024;35:s980
- Journal article: BRITISH JOURNAL OF SURGERY. 2024;111:znae175.055
- Article: CLINICAL CANCER RESEARCH. 2024;30(12):2647-2658
- Article: NATURE COMMUNICATIONS. 2024;15(1):1828
- Journal article: NATURE MEDICINE. 2024;30(11)
- Article: EUROPEAN UROLOGY OPEN SCIENCE. 2023;53:63-66
- Article: CLINICAL CHEMISTRY. 2023;69(4):386-398
- Article: ANNALS OF ONCOLOGY. 2022;33(8):750-768
- Article: ELIFE. 2022;11:e71569
- Article: ISCIENCE. 2022;25(7):104663
- Article: BIOINFORMATICS. 2022;38(13):3462-3469
- Article: PROSTATE. 2022;82(5):576-583
- Article: NATURE CANCER. 2022;3(2):251-261
- Article: FRONTIERS IN GENETICS. 2022;13:820493
- Article: CANCERS. 2021;13(7):1588
- Article: BLOOD ADVANCES. 2021;5(4):1003-1016
- Article: TRIALS. 2020;21(1):579
- Article: BLOOD CANCER JOURNAL. 2020;10(6):67
- Article: GENES. 2020;11(3):E314-314
- Article: LANCET ONCOLOGY. 2020;21(2):222-232
- Article: PROSTATE. 2019;79(8):920-928
- Article: CLINICAL CANCER RESEARCH. 2019;25(6):1766-1773
- Article: PLOS ONE. 2019;14(6):e0218280
- Article: GENOME MEDICINE. 2018;10(1):85
- Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2018;110(10):1094-1101
- Article: EUROPEAN UROLOGY FOCUS. 2018;4(5):707-710
- Article: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2018;11(1):52
- Article: HISTOPATHOLOGY. 2018;72(3):481-489
- Article: JOURNAL OF CLINICAL INVESTIGATION. 2018;128(1):341-358
- Article: BMC CANCER. 2017;17(1):802
- Article: HUMAN PATHOLOGY. 2017;69:1-7
- Article: MOLECULAR ONCOLOGY. 2017;11(10):1413-1429
- Article: LEUKEMIA. 2017;31(10):2029-2036
- Article: EUROPEAN UROLOGY. 2017;72(2):192-200
- Article: EUROPEAN UROLOGY. 2017;72(1):22-31
- Article: CLINICAL CANCER RESEARCH. 2017;23(10):2584-2592
- Article: SCIENTIFIC REPORTS. 2016;6:38037
- Article: MOLECULAR ONCOLOGY. 2016;10(6):825-837
- Article: BREAST CANCER RESEARCH. 2016;18(1):48
- Article: NATURE GENETICS. 2016;48(4):387-397
- Article: PLOS ONE. 2016;11(12):e0168153
- Article: LANCET ONCOLOGY. 2015;16(16):1667-1676
- Article: EBIOMEDICINE. 2015;2(9):1133-1144
- Article: SCIENTIFIC REPORTS. 2015;5:13426
- Article: BREAST CANCER RESEARCH AND TREATMENT. 2015;151(2):319-324
- Article: EUROPEAN UROLOGY. 2015;67(5):819-822
- Article: NEW ENGLAND JOURNAL OF MEDICINE. 2014;371(26):2477-2487
- Article: VIRCHOWS ARCHIV. 2014;465(5):559-565
- Article: BREAST CANCER RESEARCH. 2014;16(4):R72
- Article: CLINICAL CANCER RESEARCH. 2014;20(8):2169-2181
- Article: NATURE GENETICS. 2014;46(2):126-135
- Article: PLOS ONE. 2014;9(8):e104417
- Article: CANCER. 2013;119(13):2405-2412
- Article: EUROPEAN UROLOGY. 2013;63(4):702-708
- Article: EUROPEAN UROLOGY. 2013;63(2):347-353
- Article: ONCOGENE. 2012;31(35):3939-3948
- Article: CYTOKINE. 2012;57(3):406-416
- Article: PLOS ONE. 2012;7(11):e48616
- Article: PLOS ONE. 2012;7(10):e48455
- Article: PLOS ONE. 2010;5(6):e11310
- Article: BMC GENOMICS. 2010;11:241
- Article: ARTHRITIS & RHEUMATOLOGY. 2010;62(1):44-52
- Article: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(5):736-743
- Article: JOURNAL OF NEUROENDOCRINOLOGY. 2009;21(3):208-216
- Article: JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2009;2009:396808
- Article: ARTHRITIS RESEARCH & THERAPY. 2008;10(2):R33
- Article: BMC GENOMICS. 2007;8:208
- Article: PLOS ONE. 2007;2(4):e364
- Article: MOLECULAR & CELLULAR PROTEOMICS. 2007;6(1):125-132
- Article: ARTHRITIS RESEARCH & THERAPY. 2006;8(2):r47
- Article: ARTHRITIS RESEARCH & THERAPY. 2006;8(6):R179
- Show more
All other publications
- Corrigendum: NATURE MEDICINE. 2024;30(11):3381
- Preprint: MEDRXIV. 2024
- Editorial comment: EUROPEAN UROLOGY FOCUS. 2022;8(6):1617-1621
- Review: ACTA ONCOLOGICA. 2022;61(4):523-530
- Review: EUROPEAN UROLOGY FOCUS. 2021;7(4):687-691
- Preprint: ARXIV. 2021
- Preprint: BIORXIV. 2021
- Letter: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(24):2181-2182
- Letter: JAMA ONCOLOGY. 2019;5(7):1060-1062
- Editorial comment: EUROPEAN UROLOGY. 2018;74(6):739-740
- Corrigendum: EBIOMEDICINE. 2017;17:238
- Review: GENOMICS. 2010;95(1):1-6
Grants
- Liquid biopsies in metastatic prostate cancerSwedish prostate cancer foundation1 February 2024 - 1 February 2026
- Swedish Cancer Society1 January 2024
- Liquid biopsies in metastatic prostate cancerRadium Hemmets Research Funds1 January 2024 - 1 January 2026
- Detection of inactivating genomic alterations in BRCA1/2 and establishment of a tissue selection algorithm to maximise the probability of successful screening.AstraZeneca (Sweden)1 January 2024 - 31 December 2026
- Swedish Research Council1 January 2022 - 31 December 2025
- Swedish Research Council1 January 2021 - 31 December 2023
- Swedish Research Council1 January 2021 - 31 December 2024
- Swedish Cancer Society1 January 2021
- Swedish Research Council1 January 2020 - 31 December 2020
- Swedish Research Council1 January 2019 - 31 December 2022
- Swedish Research Council1 January 2018 - 31 December 2020
- Swedish Research Council1 December 2017 - 31 December 2020
- Swedish Research Council1 January 2013 - 31 December 2016
- Swedish Research Council1 January 2010 - 31 December 2012
Employments
- Principal Researcher, Department of Medical Epidemiology and Biostatistics, ̽»¨¾«Ñ¡, 2022-
Supervision
- Cecilia Merk, 2022